Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.
暂无分享,去创建一个
M. Kojima | K. Yoh | S. Umemura | K. Aokage | K. Nosaki | Y. Shibata | Y. Zenke | T. Sakai | Naoya Sakamoto | H. Izumi | Shingo Sakashita | Masahiro Tsuboi | T. Taki | Genichiro Ishii | Shingo Matsumoto | Shingo Kitagawa | Koichi Goto